Jeil Pharm (002620)

Seoul
24,900.00
0.00(0.00%)
  • Volume:
    38,263
  • Bid/Ask:
    24,900.00/24,950.00
  • Day's Range:
    23,700.00 - 25,100.00

002620 Overview

Prev. Close
24,900
Day's Range
23,700 - 25,100
Revenue
762B
Open
23,950
52 wk Range
14,300 - 33,000
EPS
744.64
Volume
38,263
Market Cap
397.74B
Dividend (Yield)
70.00 (0.28%)
Average Vol. (3m)
27,031
P/E Ratio
33.44
Beta
2.05
1-Year Change
70.89%
Shares Outstanding
15,351,125
Next Earnings Date
May 19, 2021
What is your sentiment on Jeil Pharm?
or
Vote to see community's results!

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellBuySellBuyStrong Buy
Technical IndicatorsSellSellSellStrong BuyBuy
SummaryStrong SellNeutralSellStrong BuyStrong Buy

Jeil Pharm Company Profile

Jeil Pharm Company Profile

Employees
1190

JEIL PHARMA HOLDINGS INC., formerly Jeil Pharmaceutical Co.,Ltd is a Korea-based company mainly engaged in the manufacture and distribution of pharmaceuticals. The Company provides antibiotics, anti-inflammatory painkillers, hepatitis remedies, duodenum ulcer treatments, anticancer drugs, tristimania drugs, gastritis drugs, stomach ulcer drugs, septicemia treatments, pollakisuria treatments, acute bronchitis remedies, hyperlipidemia treatments and others. The Company distributes its products within domestic market and to overseas markets.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.